Mock James M
Chief Financial Officer
In the last 12 months, Mock James M filed 55 SEC Form 4 transactions across 1 issuer — $0 in open-market purchases and $0 in open-market sales. 0% of these transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $0Open-market buys (1y)
- $0Open-market sells (1y)
- 55Transactions filed
- 1Distinct issuers
- 0%Under Rule 10b5-1
- 2026-06-05Latest filing
Issuers Filed For By open-market buy volume
Recent Form 4 Filings Most recent 55 of 55 (1-year window)
| Date | Ticker | Company | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | MRNA | Moderna, Inc. | Exercise | M | $0 | 11,798 | — |
| 2026-06-05 | MRNA | Moderna, Inc. | Exercise | M | $0 | 11,798 | $0.00 |
| 2026-06-05 | MRNA | Moderna, Inc. | Other | F | $294.3K | 5,705 | $51.59 |
| 2026-06-01 | MRNA | Moderna, Inc. | Exercise | M | $0 | 2,475 | — |
| 2026-06-01 | MRNA | Moderna, Inc. | Exercise | M | $0 | 2,475 | $0.00 |
| 2026-06-01 | MRNA | Moderna, Inc. | Other | F | $56.5K | 1,197 | $47.19 |
| 2026-05-28 | MRNA | Moderna, Inc. | Exercise | M | $0 | 328 | — |
| 2026-05-28 | MRNA | Moderna, Inc. | Exercise | M | $0 | 328 | $0.00 |
| 2026-05-28 | MRNA | Moderna, Inc. | Other | F | $7.6K | 159 | $47.61 |
| 2026-05-27 | MRNA | Moderna, Inc. | Exercise | M | $0 | 773 | — |
| 2026-05-27 | MRNA | Moderna, Inc. | Exercise | M | $0 | 773 | $0.00 |
| 2026-05-27 | MRNA | Moderna, Inc. | Other | F | $17.6K | 374 | $47.03 |
| 2026-04-02 | MRNA | Moderna, Inc. | Exercise | M | $0 | 1,453 | — |
| 2026-04-02 | MRNA | Moderna, Inc. | Exercise | M | $0 | 1,453 | $0.00 |
| 2026-04-02 | MRNA | Moderna, Inc. | Other | F | $35.2K | 703 | $50.03 |
| 2026-03-05 | MRNA | Moderna, Inc. | Grant | — | $0 | 11,797 | — |
| 2026-03-05 | MRNA | Moderna, Inc. | Grant | — | $329.7K | 5,704 | $57.80 |
| 2026-03-05 | MRNA | Moderna, Inc. | Grant | — | $0 | 11,797 | $0.00 |
| 2026-03-01 | MRNA | Moderna, Inc. | Grant | — | $0 | 37,639 | $0.00 |
| 2026-03-01 | MRNA | Moderna, Inc. | Grant | — | $0 | 49,569 | $0.00 |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 329 | — |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $8.3K | 160 | $51.71 |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 774 | — |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $19.4K | 375 | $51.71 |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 9,901 | — |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $247.6K | 4,788 | $51.71 |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 329 | $0.00 |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 774 | $0.00 |
| 2026-02-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 9,901 | $0.00 |
| 2026-02-11 | MRNA | Moderna, Inc. | Grant | — | $0 | 2,630 | $0.00 |
| 2026-02-11 | MRNA | Moderna, Inc. | Grant | — | $53.7K | 1,278 | $41.99 |
| 2026-01-05 | MRNA | Moderna, Inc. | Grant | — | $0 | 1,452 | — |
| 2026-01-05 | MRNA | Moderna, Inc. | Grant | — | $24.1K | 780 | $30.86 |
| 2026-01-05 | MRNA | Moderna, Inc. | Grant | — | $0 | 1,452 | $0.00 |
| 2025-12-05 | MRNA | Moderna, Inc. | Grant | — | $0 | 47,190 | — |
| 2025-12-05 | MRNA | Moderna, Inc. | Grant | — | $581.6K | 22,817 | $25.49 |
| 2025-12-05 | MRNA | Moderna, Inc. | Grant | — | $0 | 47,190 | $0.00 |
| 2025-11-28 | MRNA | Moderna, Inc. | Grant | — | $0 | 329 | — |
| 2025-11-28 | MRNA | Moderna, Inc. | Grant | — | $4.0K | 160 | $25.01 |
| 2025-11-28 | MRNA | Moderna, Inc. | Grant | — | $0 | 329 | $0.00 |
| 2025-11-26 | MRNA | Moderna, Inc. | Grant | — | $0 | 773 | — |
| 2025-11-26 | MRNA | Moderna, Inc. | Grant | — | $9.3K | 374 | $24.75 |
| 2025-11-26 | MRNA | Moderna, Inc. | Grant | — | $0 | 773 | $0.00 |
| 2025-10-03 | MRNA | Moderna, Inc. | Grant | — | $0 | 1,453 | — |
| 2025-10-03 | MRNA | Moderna, Inc. | Grant | — | $19.9K | 703 | $28.37 |
| 2025-10-03 | MRNA | Moderna, Inc. | Grant | — | $0 | 1,453 | $0.00 |
| 2025-08-28 | MRNA | Moderna, Inc. | Grant | — | $0 | 329 | — |
| 2025-08-28 | MRNA | Moderna, Inc. | Grant | — | $4.0K | 160 | $25.10 |
| 2025-08-28 | MRNA | Moderna, Inc. | Grant | — | $0 | 329 | $0.00 |
| 2025-08-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 774 | — |
| 2025-08-27 | MRNA | Moderna, Inc. | Grant | — | $9.3K | 375 | $24.73 |
| 2025-08-27 | MRNA | Moderna, Inc. | Grant | — | $0 | 774 | $0.00 |
| 2025-07-03 | MRNA | Moderna, Inc. | Grant | — | $0 | 1,453 | — |
| 2025-07-03 | MRNA | Moderna, Inc. | Grant | — | $21.3K | 703 | $30.28 |
| 2025-07-03 | MRNA | Moderna, Inc. | Grant | — | $0 | 1,453 | $0.00 |
Methodology & FAQ
How These Filings Are Sourced
All transactions on this page are sourced directly from SEC EDGAR. A complete description of the open-market vs grant distinction, the Rule 10b5-1 plan-reference heuristic, and the per-insider name matching is documented in the Methodology.
What companies does Mock James M file Form 4 disclosures for?
Mock James M has filed SEC Form 4 transactions for 1 issuer in the last 12 months: Moderna, Inc. (MRNA).
What does the 10b5-1 badge mean on these transactions?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Of Mock James M's 55 reported transactions in the last 12 months, 0 (0%) reference a 10b5-1 trading plan in the Form 4 footnotes.
Are these all the transactions Mock James M has executed?
This page shows SEC Form 4 transactions on record in Pactolio's tracked universe for the last 12 months. Form 4 only covers transactions in registered classes of equity at issuers where the person qualifies as an insider (officer, director, or 10% beneficial owner). Trades in funds, foreign issuers, or non-insider positions are not disclosed under Form 4 and are not included here.